Journal Article
. 2021 Mar; 7(1):20.
doi: 10.1038/s41523-021-00231-x.

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer

Della Makower 1 Juan Lin 2 Xiaonan Xue 2 Joseph A Sparano 3 
  • PMID: 33649322
  •     54 References


Lymphovascular invasion (LVI) and Black race are associated with poorer prognosis in early breast cancer (EBC). We evaluated the association between LVI and race, and whether LVI adds prognostic benefit to the 21-gene recurrence score (RS) in EBC. Women with ER+ HER2- EBC measuring up to 5 cm, with 0-3 involved axillary nodes, diagnosed between 1 January 2010 and 1 January 2014, who underwent surgery as first treatment and had available RS, were identified in the NCDB database. Bivariate associations between two categorical variables were examined using chi-square test. Multivariate Cox proportional hazards model were used to assess the association of LVI, race, and other covariates with overall survival (OS). 77,425 women, 65,018 node-negative (N0), and 12,407 with 1-3 positive (N+) nodes, were included. LVI was present in 12.7%, and associated with poor grade, RS 26-100, and N+ (all p < 0.0001), but not Black race. In multivariate analysis, LVI was associated with worse OS in N0 [HR 1.37 (95% CI 1.27, 1.57], but not N+ EBC. LVI was associated with worse OS in N0 patients with RS 11-25 [HR 1.31 (95% CI 1.09, 1.57)] and ≥26 [HR 1.58 (95% CI 1.30, 1.93)], but not RS 0-10. No interaction between LVI and chemotherapy benefit was seen. Black race was associated with worse OS in N0 (HR 1.21, p = 0.009) and N+ (HR 1.37, p = 0.015) disease. LVI adds prognostic information in ER+, HER2-, N0 BCA with RS 11-100, but does not predict chemotherapy benefit. Black race is associated with worse OS, but not LVI.

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn.
J Clin Oncol, 2003 Feb 15; 21(4). PMID: 12586795
Highly Cited.
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
L Mauriac, A Keshaviah, +19 authors, International Breast Cancer Study Group.
Ann Oncol, 2007 Feb 16; 18(5). PMID: 17301074
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
Kazumasa Matsumoto, Giacomo Novara, +24 authors, Shahrokh F Shariat.
BJU Int, 2011 Apr 22; 108(8 Pt 2). PMID: 21507184
Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers.
I de Mascarel, F Bonichon, +7 authors, M Trojani.
Eur J Cancer, 1998 Jun 13; 34(1). PMID: 9624238
The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression.
Gina Kim, Jessica M Pastoriza, +4 authors, Maja H Oktay.
Front Oncol, 2020 Jul 28; 10. PMID: 32714862    Free PMC article.
Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.
A H S Lee, S E Pinder, +4 authors, R W Blamey.
Eur J Cancer, 2005 Dec 27; 42(3). PMID: 16377180
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
Idan Menashe, William F Anderson, Ismail Jatoi, Philip S Rosenberg.
J Natl Cancer Inst, 2009 Jul 09; 101(14). PMID: 19584327    Free PMC article.
Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.
Mohammed A Aleskandarany, Sultan N Sonbul, Abhik Mukherjee, Emad A Rakha.
Pathobiology, 2015 Sep 04; 82(3-4). PMID: 26330352
Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.
Tulay Koru-Sengul, Ana M Santander, +9 authors, Marta Torroella-Kouri.
Breast Cancer Res Treat, 2016 Jun 11; 158(1). PMID: 27283835    Free PMC article.
Racial disparities in treatment and survival among women with early-stage breast cancer.
Dawn Hershman, Russell McBride, +4 authors, Alfred I Neugut.
J Clin Oncol, 2005 Sep 20; 23(27). PMID: 16170171
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
Gulisa Turashvili, Joanne F Chou, +5 authors, Hannah Y Wen.
Breast Cancer Res Treat, 2017 Jul 14; 166(1). PMID: 28702894    Free PMC article.
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Kathy S Albain, Joseph M Unger, +2 authors, Dawn L Hershman.
J Natl Cancer Inst, 2009 Jul 09; 101(14). PMID: 19584328    Free PMC article.
Highly Cited.
Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profiles.
Sukhontip Klahan, Henry Sung-Ching Wong, +9 authors, Wei-Chiao Chang.
Tumour Biol, 2017 Jun 28; 39(6). PMID: 28651487
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.
Vladimir Riabov, Alexandru Gudima, +3 authors, Julia Kzhyshkowska.
Front Physiol, 2014 Mar 19; 5. PMID: 24634660    Free PMC article.
Highly Cited. Review.
Using the NCDB for cancer care improvement: an introduction to available quality assessment tools.
Mehul V Raval, Karl Y Bilimoria, +2 authors, Clifford Y Ko.
J Surg Oncol, 2009 May 26; 99(8). PMID: 19466738
Differences in the tumor microenvironment between African-American and European-American breast cancer patients.
Damali N Martin, Brenda J Boersma, +9 authors, Stefan Ambs.
PLoS One, 2009 Feb 20; 4(2). PMID: 19225562    Free PMC article.
VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival.
Sebastian F Schoppmann, Alexandra Fenzl, +7 authors, Peter Birner.
Surgery, 2006 Jun 20; 139(6). PMID: 16782443
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Michaela A Dinan, Xiaojuan Mi, +2 authors, Lesley H Curtis.
JAMA Oncol, 2015 Aug 28; 1(8). PMID: 26313372
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.
Sachin Kumar Deshmukh, Sanjeev K Srivastava, +7 authors, Seema Singh.
Carcinogenesis, 2017 Apr 22; 38(8). PMID: 28430867    Free PMC article.
21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile.
Jagar Jasem, Arya Amini, +4 authors, Peter Kabos.
J Clin Oncol, 2016 Mar 24; 34(17). PMID: 27001563    Free PMC article.
Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer.
Yani Lu, Huiyan Ma, +12 authors, Leslie Bernstein.
J Clin Oncol, 2011 Jul 27; 29(25). PMID: 21788570    Free PMC article.
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103.
Bryan P Schneider, Fei Shen, +9 authors, Kathy D Miller.
JCO Precis Oncol, 2018 Jan 16; 2017. PMID: 29333527    Free PMC article.
Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling.
Raz Mutai, Hadar Goldvaser, +3 authors, Rinat Yerushalmi.
Oncology, 2018 Sep 27; 96(1). PMID: 30253418
Impact of routine pathology review on treatment for node-negative breast cancer.
Hagen F Kennecke, Caroline H Speers, +3 authors, Malcolm Hayes.
J Clin Oncol, 2012 May 09; 30(18). PMID: 22564990
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.
Olivia Pagani, Prudence A Francis, +13 authors, SOFT and TEXT Investigators and International Breast Cancer Study Group.
J Clin Oncol, 2019 Oct 17; 38(12). PMID: 31618131    Free PMC article.
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
Joseph A Sparano, Molin Wang, +9 authors, Nancy E Davidson.
J Natl Cancer Inst, 2012 Jan 18; 104(5). PMID: 22250182    Free PMC article.
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
Jonathan Chen, Xian Wu, +2 authors, Himanshu Nagar.
Breast Cancer Res, 2018 Apr 18; 20(1). PMID: 29661221    Free PMC article.
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
Oleg Gluz, Ulrike A Nitz, +18 authors, Nadia Harbeck.
J Clin Oncol, 2016 Mar 02; 34(20). PMID: 26926676
Highly Cited.
Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype.
Yousif A Kariri, Mohammed A Aleskandarany, +5 authors, Emad A Rakha.
Pathobiology, 2020 Jul 10; 87(4). PMID: 32645698
Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium.
Chi-Chen Hong, Lara E Sucheston-Campbell, +17 authors, Christine B Ambrosone.
Cancer Epidemiol Biomarkers Prev, 2018 Jan 18; 27(3). PMID: 29339359    Free PMC article.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.
Robert Lindner, Catherine Sullivan, +8 authors, Lyndsay N Harris.
PLoS One, 2013 Nov 22; 8(11). PMID: 24260093    Free PMC article.
Racial differences in breast carcinoma survival.
S A Joslyn, M M West.
Cancer, 2000 Jan 05; 88(1). PMID: 10618613
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge.
N Engl J Med, 2018 Jun 05; 379(2). PMID: 29860917    Free PMC article.
Highly Cited.
Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
Young Jae Ryu, Shin Jae Kang, +2 authors, Min Ho Park.
Medicine (Baltimore), 2018 Jul 26; 97(30). PMID: 30045313    Free PMC article.
Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
Lisa A Newman, Cheryl T Lee, +8 authors, American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
Cancer, 2005 Dec 08; 106(1). PMID: 16333856
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.
M Colleoni, N Rotmensz, +12 authors, G Viale.
Ann Oncol, 2007 Aug 25; 18(10). PMID: 17716986
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.
A C Voogd, M Nielsen, +8 authors, Danish Breast Cancer Cooperative Group. Breast Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.
J Clin Oncol, 2001 Mar 17; 19(6). PMID: 11250998
Highly Cited.
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Lyndsay N Harris, Nofisat Ismaila, +11 authors, American Society of Clinical Oncology.
J Clin Oncol, 2016 Feb 10; 34(10). PMID: 26858339    Free PMC article.
Highly Cited. Review.
Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.
Joseph A Sparano, Fengmin Zhao, +7 authors, Nancy E Davidson.
J Clin Oncol, 2015 Jun 17; 33(21). PMID: 26077235    Free PMC article.
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
G Viale, A Giobbie-Hurder, +16 authors, A S Coates.
Ann Oncol, 2009 Jul 28; 21(2). PMID: 19633051    Free PMC article.
Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014.
Katherine Mallin, Amanda Browner, +8 authors, Heidi Nelson.
Ann Surg Oncol, 2019 Feb 10; 26(6). PMID: 30737668
Highly Cited.
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.
Joseph A Sparano, Molin Wang, +10 authors, Nancy E Davidson.
Cancer, 2012 Aug 29; 118(23). PMID: 22926690    Free PMC article.
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Ulrike Nitz, Oleg Gluz, +18 authors, Nadia Harbeck.
Breast Cancer Res Treat, 2017 Jul 01; 165(3). PMID: 28664507    Free PMC article.
Disparities in Breast Cancer Stage at Diagnosis: Importance of Race, Poverty, and Age.
Faustine Williams, Emmanuel Thompson.
J Health Dispar Res Pract, 2017 Oct 01; 10(3). PMID: 30637180    Free PMC article.
Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.
Aaron C Tan, Bob T Li, +11 authors, Gavin M Marx.
Asia Pac J Clin Oncol, 2017 Sep 30; 14(2). PMID: 28960862    Free PMC article.
Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer.
Tor A Klingen, Ying Chen, +2 authors, Lars A Akslen.
Hum Pathol, 2017 Sep 20; 69. PMID: 28923419
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
Ian Krop, Nofisat Ismaila, +10 authors, Vered Stearns.
J Clin Oncol, 2017 Jul 12; 35(24). PMID: 28692382    Free PMC article.
Highly Cited.
The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer.
Young Ju Song, Sun Hyoung Shin, +3 authors, Young Jong Jegal.
J Breast Cancer, 2011 Oct 28; 14(3). PMID: 22031801    Free PMC article.
Development of the 21-gene assay and its application in clinical practice and clinical trials.
Joseph A Sparano, Soonmyung Paik.
J Clin Oncol, 2008 Feb 09; 26(5). PMID: 18258979
Highly Cited. Review.
Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia.
Lindsay J Collin, Ming Yan, +8 authors, Lauren E McCullough.
NPJ Breast Cancer, 2019 Oct 05; 5. PMID: 31583272    Free PMC article.
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, +14 authors, Robert C Millikan.
JAMA, 2006 Jun 08; 295(21). PMID: 16757721
Highly Cited.